Back to Selection     Print       Date : 31 May 2025
Fund Summary
ITI Pharma and Healthcare Fund Reg (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 08-Nov-2021
Corpus(Cr.) 221.0 Latest NAV 16.3867 As on 10-07-2025
Equity(%) 99.7 52 Week High 17.6024
Debt(%) 0.3 52 Week Low 14.552
Others(%) 0.0 Exit Load 0.5% for redemption within 3 months
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.35
Scheme Benchmark NIFTY Healthcare TRI. Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Rohan Korde
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 40.31%
Top 10 Holdings 59.18%
Top 25 Holdings 85.44%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 73.27
Healthcare 20.25
Fertilisers 2.57
Chemicals 2.0
Software & Services 1.29
SERVICES 0.32
Cash 0.3
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.84
PE Ratio 30.22
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 15.18
DIVI LABORATORIES LTD 9.12
Max Healthcare Institute Limited 5.42
Lupin Limited 5.40
Apollo Hospitals Enterprise Limited 5.19
Cohance Lifesciences Limited 4.84
Aurobindo Pharma Limited 3.93
Torrent Pharmaceuticals Limited 3.91
Aster DM Healthcare Limited 3.15
Mankind Pharma Limited 3.04
Alkem Laboratories Limited 2.87
Fortis Health Care Ltd 2.43
Abbott India Limited 2.33
Wockhardt Limited 2.28
Granules India Limited 2.11
Neuland Laboratories Limited 1.98
FDC Limited 1.55
Healthcare Global Enterprises Limited 1.55
Supriya Lifescience Limited 1.48
Sumitomo Chemical India Limited 1.43
Sagility India Limited 1.29
Rainbow Childrens Medicare Limited 1.28
Vijaya Diagnostic Centre Limited 1.23
J B Chemicals and Pharma Ltd 1.23
Dr Reddys Laboratories Limited 1.22

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
1.17% 10.38% -2.10% 11.35%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.22% 13.80% 9.05% 5.49%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
1.44% 10.36% 0.81% 10.96%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
26.11% 22.68% 0.00% 0.00%
 
 
15.83% 17.36% 20.09% 13.10%
 
 
27.91% 23.95% 20.48% 8.63%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
 
Back to Selection